Neurological focus Target NeuroOne's core focus on minimally invasive and hi-definition solutions for epilepsy, Parkinson’s disease, essential tremors and other neurological disorders to tailor outreach to neurology and neurosurgery departments, research centers, and hospital systems investing in advanced brain mapping and treatment technologies.

Early-stage growth Leverage NeuroOne’s developmental stage and recent product launches such as the OneRF Ablation System to position as a partner for co-development, clinical trials, and early adoption programs with hospitals seeking differentiated neuroscience devices and procedural cost reductions.

Strategic leadership Engage with the executive team’s recent appointments and strategic promotions to align value propositions around drug delivery platforms, Operational excellence, and partnerships, targeting collaborations with pharma, device distributors, and academic medical centers.

Funding and partnerships Capitalize on NeuroOne’s funding level and growth trajectory to propose co-investment, grant-backed studies, and milestone-driven partnerships with medical device distributors, contract research organizations, and clinical research networks seeking novel neuromodulation tools.

Market positioning Position NeuroOne against peers with high R&D intensity and targeted neurological applications to highlight potential cost savings, improved targeting, and expanded indications, while pursuing opportunities with mid-to-large neuro-focused healthcare systems and specialty hospitals.